ANAPLASTIC THYROID CANCER

This adverse event was reported 121 times

These drugs are most commonly taken by patients reporting ANAPLASTIC THYROID CANCER:

# Drug Count
0 DABRAFENIB 48
1 TRAMETINIB 44
2 METHOTREXATE 8
3 METHOTREXATE SODIUM 8
4 APREMILAST 7
5 LEFLUNOMIDE 6
6 RITUXIMAB 6
7 DEXAMETHASONE 5
8 DEXAMETHASONE 1.5 MG 5
9 LENVATINIB 5
See all common drugs associated with ANAPLASTIC THYROID CANCER

ANAPLASTIC THYROID CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DABRAFENIB 48 0.0023
1 TRAMETINIB 44 0.0018
2 AZILSARTAN KAMEDOXOMIL 1 0.0003
3 MICAFUNGIN SODIUM 2 0.0003
4 ACARBOSE 1 0.0003
5 BINIMETINIB 2 0.0003
6 BAYER ASPIRIN EXTRA STRENGTH 1 0.0003
7 ENCORAFENIB 2 0.0002
8 PITAVASTATIN CALCIUM 2 0.0002
9 BETAMETHASONE DIPROPIONATE 1 0.0001
See all drugs enriched for association with ANAPLASTIC THYROID CANCER